Incyte (INCY) Cost of Revenue (2012 - 2026)

Incyte's Cost of Revenue history runs 15 years deep, the most recent figure standing at $104.5 million for Q1 2026.

• Quarterly Cost of Revenue rose 42.81% year-over-year to $104.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $403.5 million (up 24.41% YoY) and the FY2025 annual result came in at $372.1 million, up 19.25% from the prior year.
• Cost of Revenue was $104.5 million for Q1 2026 at Incyte, down from $121.2 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $121.2 million in Q4 2025 and bottomed at $42.6 million in Q1 2022.
• A 5-year average of $73.6 million and a median of $69.8 million in 2023 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2022 — Cost of Revenue surged 45.84% — and 2025, when it advanced 2.78%.
• Incyte's Cost of Revenue stood at $59.2 million in 2022, then rose by 17.9% to $69.8 million in 2023, then climbed by 26.86% to $88.5 million in 2024, then soared by 36.94% to $121.2 million in 2025, then fell by 13.74% to $104.5 million in 2026.
• Business Quant data shows INCY's Cost of Revenue at $104.5 million in Q1 2026, $121.2 million in Q4 2025, and $99.0 million in Q3 2025.